Anthropic Hires OpenAI CoFounder Andrej Karpathy Former Tesla AI Leader Warren Buffetts Estate Plan 90 of His Wifes Inheritance in One Investment Strategy and Lessons Is United UPS Still a Buy After 051 Rally 20260515 VeriSign VRSN Q1 2026 Beat Revenue NA EPS Exceeds by Significant Markets Shift Expectations Fed Rate Hike Scenario Gains Traction After Hot Inflation Data SoundHound AI SOUN Advances Agentic AI Capabilities Opportunities and Market Impact SP 500 Edges Higher as Healthcare and Tech Rally Communication Services Lags Bank Closures on Memorial Day A Guide to the 12 Federal Holidays Telecoms CEO Warns Europe Faces Strategic Risk from US Satellite and AI Dominance BJs Wholesale Club Plans Major Store Changes Amid Consumer Spending Pullback ADSK Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Despite Strong Quarter Hub Group Q3 2025 Earnings EPS Falls Short of Estimates Stock Declines C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress MNDY Q1 2026 Earnings Strong EPS Beat Highlights Operational Discipline CNS Q1 2026 Earnings EPS Misses Estimates by 34 Stock Declines CNMD Q1 2026 Earnings Adjusted EPS Surpasses Consensus Shares Edge Higher Xos Inc XOS Slips to 20 Navigating Key Support at 19 Origin Investment Corp I Warrant ORIQW Holds Steady at 016 Amid Tight Trading Range MFS Multimarket Income Trust MMT Holds Steady at 449 as Trading Range Narrows PS International Group PSIG Surges 183 as Stock Tests Key Resistance Level at 82 Woodside Energy WDS Gains 106 as Shares Test Key Resistance MSGS Q1 2026 Earnings Heavy EPS Miss Amid Stock Rally Highlights Market Optimism CALX Q1 2026 Earnings EPS Matches Estimates Stock Rises 211 BayCom Corp Q1 2026 Earnings EPS Smashes Estimates by 226 but Shares Slip STRO Q1 2026 Earnings Narrowing Losses Beat Estimates Stock Gains 7 FCAP Q1 2026 Earnings EPS of 130 Highlights Cost Discipline Amid Modest Operating Environment Hong Kong Airport Expansion May Accelerate Competition in Greater Bay Area Aviation Scholastic Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Intellia Therapeutics NTLA Nears Key Support Amid Continued Downtrend